KIF11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.783400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.882200E-01
Normal-vs-Stage2
4.059800E-01
Normal-vs-Stage3
9.386000E-01
Normal-vs-Stage4
8.158600E-01
Stage1-vs-Stage2
5.432800E-01
Stage1-vs-Stage3
8.287200E-01
Stage1-vs-Stage4
9.850600E-01
Stage2-vs-Stage3
4.020000E-01
Stage2-vs-Stage4
5.945200E-01
Stage3-vs-Stage4
8.577400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.949600E-01
Normal-vs-AfricanAmerican
6.848600E-01
Normal-vs-Asian
2.103200E-01
Caucasian-vs-AfricanAmerican
8.238200E-01
Caucasian-vs-Asian
3.803400E-01
AfricanAmerican-vs-Asian
4.319200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.119200E-01
Normal-vs-Female
4.531800E-01
Male-vs-Female
6.059600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.597200E-01
Normal-vs-Age(41-60Yrs)
4.407000E-01
Normal-vs-Age(61-80Yrs)
5.150000E-01
Normal-vs-Age(81-100Yrs)
3.297600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.089800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.551400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.490600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.385600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.794200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.090400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.472200E-01
Normal-vs-Daily Drinker
4.296400E-01
Normal-vs-Weekly Drinker
4.105000E-01
Normal-vs-Occasional Drinker
3.929400E-01
Normal-vs-Social Drinker
6.685200E-01
Non Drinker-vs-Daily Drinker
5.432000E-01
Non Drinker-vs-Weekly Drinker
6.069600E-01
Non Drinker-vs-Occasional Drinker
5.447400E-01
Non Drinker-vs-Social Drinker
7.367000E-01
Daily Drinker-vs-Weekly Drinker
9.713600E-01
Daily Drinker-vs-Occasional Drinker
9.953200E-01
Daily Drinker-vs-Social Drinker
4.229600E-01
Weekly Drinker-vs-Occasional Drinker
9.664200E-01
Weekly Drinker-vs-Social Drinker
4.589000E-01
Occasional Drinker-vs-Social Drinker
4.102800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.657200E-01
Normal-vs-Grade 2
8.064200E-01
Normal-vs-Grade 3
8.525200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.135560E-03
Grade 1-vs-Grade 3
3.604200E-04
Grade 1-vs-Grade 4
6.657200E-01
Grade 2-vs-Grade 3
2.811400E-01
Grade 2-vs-Grade 4
8.064200E-01
Grade 3-vs-Grade 4
8.525200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.776000E-01
Normal-vs-NonDiabetic
4.221000E-01
Diabetic-vs-NonDiabetic
2.251400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.654190E-01
Normal-vs-NoPancreatitis
5.084200E-01
Pancreatitis-vs-NoPancreatitis
2.609400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.373800E-01
Normal-vs-N1
4.539400E-01
N0-vs-N1
8.109800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.645600E-02
Normal-vs-TP53-NonMutant
5.601200E-01
TP53-Mutant-vs-TP53-NonMutant
5.54640000038908E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
